Veradermics (MANE) earnings, Jul 28, 2026: EPS −17%, stock +0.1%
In brief
Veradermics reported on Jul 28, 2026. Earnings per share changed −17% year over year, 13.1% above the estimate; revenue 0%. The stock opened with a +1.2% gap and closed the day +0.1% (Jul 28, 2026). The stock is now 12.3% below its 52-week high. Next report: Dec 2, 2026.
EPS vs estimate+13.1%
EPS, YoY−17%
Revenue, YoY0%
Gap · day+1.2% · +0.1%
EPS growth by quarter, YoY
Price reaction to earnings
| Report | Gap | Day |
|---|---|---|
| Mar 31, 2026 | +3.2% | −6.9% |
| Jun 30, 2026 | −2.9% | −0.5% |
| Jul 28, 2026 | +1.2% | +0.1% |
Next-quarter estimates, ratings and the MANE chart are in the terminal.
Open the terminalFAQ
When is Veradermics's next earnings report?
Dec 2, 2026. The date comes from daily data and is corrected if the company moves it.
How did Veradermics stock react to the report?
Opening gap +1.2%, day's result +0.1%.
Did Veradermics's earnings grow?
Earnings per share fell 17% year over year.
What is an earnings gap?
The jump between the close before and the open after the report. A big gap up often means large buyers are revaluing the company.